These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9255801)

  • 21. [Immunogenicity of purified tetanus anatoxin fractions isolated on an ion-exchange column].
    Izmaĭlova MK
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):120-4. PubMed ID: 5477599
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetanus toxoid-loaded transfersomes for topical immunization.
    Gupta PN; Mishra V; Singh P; Rawat A; Dubey P; Mahor S; Vyas SP
    J Pharm Pharmacol; 2005 Mar; 57(3):295-301. PubMed ID: 15807984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibilities of expanding the raw material base for obtaining immunologic preparations from donors' blood].
    Fedorovskaia EA; Nazarchuk LV; Kucher II
    Gematol Transfuziol; 1987 Mar; 32(3):56-7. PubMed ID: 3582940
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors associated with TT (tetanus toxoid) immunization among pregnant women, in Saparua, Maluku, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):91-5. PubMed ID: 11023073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased in vitro cellular response to tetanus toxoid and tuberculin in patients using topical corticosteroids.
    Wang G; Molander G; Koivuluhta M; Alenius H; Lauerma A
    Acta Derm Venereol; 2005; 85(4):296-8. PubMed ID: 16191848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of granuloma annulare in a child following tetanus and diphtheria toxoid vaccination.
    Baskan EB; Tunali S; Kacar SD; Adim SB; Saricaoglu H
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):639-40. PubMed ID: 16164728
    [No Abstract]   [Full Text] [Related]  

  • 28. Practice and knowledge regarding prevention of tetanus among nursing personnel in Delhi.
    Kumar R; Taneja DK; Dabas P; Ingle GK
    Indian J Public Health; 2007; 51(1):73-4. PubMed ID: 18232153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do unsafe tetanus toxoid injections play a significant role in the transmission of HIV/AIDS? Evidence from seven African countries.
    de Walque D
    Sex Transm Infect; 2008 Apr; 84(2):122-5. PubMed ID: 18192293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractionation of tetanus toxoid by gel filtration.
    Komorowska-Rycerz A; Brühl A; Krauze R
    Bull Acad Pol Sci Biol; 1966; 14(2):81-4. PubMed ID: 5939551
    [No Abstract]   [Full Text] [Related]  

  • 31. Qualitative study of knowledge and behaviours related to tetanus toxoid immunization among women of childbearing age in rural China.
    You X; Kobayashi Y; Yang J; Zhu X; Liang X
    Public Health; 2007 Mar; 121(3):227-30. PubMed ID: 17241648
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there a causative role for tetanus toxoid vaccination in the development of allergy-like symptoms and in the increasing prevalence of atopic diseases?
    Mari A
    Med Hypotheses; 2004; 63(5):875-86. PubMed ID: 15488663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scaling up interventions to eliminate neonatal tetanus: factors associated with the coverage of tetanus toxoid and clean deliveries among women in Vientiane, Lao PDR.
    Masuno K; Xaysomphoo D; Phengsavanh A; Douangmala S; Kuroiwa C
    Vaccine; 2009 Jul; 27(32):4284-8. PubMed ID: 19450637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge, attitude and practices of reproductive age females about tetanus toxoid vaccine: a pilot study.
    Zeb A; Zaidi SA; Jehan I
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):791-3. PubMed ID: 17125643
    [No Abstract]   [Full Text] [Related]  

  • 36. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States.
    Mink CM
    Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991
    [No Abstract]   [Full Text] [Related]  

  • 37. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Tierney R; Gaines-Das R
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increased level of tetanus antibody twenty one years after a booster dose of tetanus vaccine].
    Geraldes F; Queirós L; Santos MA
    Acta Med Port; 2004; 17(2):183-6. PubMed ID: 15921651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deferral of routine booster doses of tetanus and diphtheria toxoids for adolescents and adults.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(20):418, 427. PubMed ID: 11400958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.